EC approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis
Eli Lilly and Company and Incyte Corporation announced that the EC has granted marketing authorisation for Olumiant® (baricitinib) 4 mg and 2 mg film-coated...
Allergan Launches See America , a Bold Initiative Furthering the Fight Against Preventable Blindness
Allergan plc , a global leader in eye care for nearly 70 years, announces a bold commitment to fight preventable blindness in the United...
Arven Pharma selects GE Healthcare to improve Turkish and regional access to biopharmaceuticals
Arven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility in Kirklareli, Turkey. With...
NeuroVive reallocate research resources from the Asian subsidiary of the parent company
NeuroVive Pharmaceutical AB , a company in mitochondrial medicine announced that research resources and activities of the Taiwan-based subsidiary redirected to the parent company...
Jitsubo and Japanese pharma company Enter License Agreement and Collaboration for cardiovascular disease
Jitsubo Co., Ltd. announced that it has executed the joint development and license agreement with a Japanese pharmaceutical company (undisclosed) on JIT-2001 (development code)...
COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator
The COPD Foundation-sponsored COPD Biomarker Qualification Consortium announced that it has partnered with the Bio Techne Cor, a manufacturer of biotechnology products for life...
Adaptive Biotechnologies, Amgen partner to develop sequencing-based ALL assay
Adaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, announces...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...